Lipaglyn™ is the first Glitazar to be approved in the world and is the first New Chemical Entity (NCE) discovered and developed indigenously by an Indian Pharma Company.
Thetis Pharmaceuticals is innovating and developing best-in-class prescription drugs for the treatment of cardio-metabolic disorders including type 2 diabetes, hypertriglyceridemia, non-HDL cholesterol and atrial fibrillation.
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Learn about VASCEPA® (icosapent ethyl), a medication that can help reduce triglyceride levels in adult patients with severe high triglycerides (hypertriglyceridemia).
Palmetto has shown that the combination of sustained release L-arginine and statin significantly reduces triglycerides beyond that by statin alone, and has exceptional intellectual property protection